National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 19765-19766 [2020-07407]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 68 / Wednesday, April 8, 2020 / Notices
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Planning Grant (R34) and Implementation
Cooperative Agreement (U01).
Date: April 30, 2020.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Mohammed S. Aiyegbo,
Ph.D., Scientific Review Officer, AIDS
Research Review Branch, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3E70, Rockville, MD
20852, 301–761–7106 mohammed.aiyegbo@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 2, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–07408 Filed 4–7–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSKBCFDHB2PROD with NOTICES
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Senator Paul D.
Wellstone Muscular Dystrophy Specialized
Research Centers Review.
Date: April 24, 2020.
Time: 8:00 a.m. to 6:00 p.m.
VerDate Sep<11>2014
18:37 Apr 07, 2020
Jkt 250001
Agenda: To review and evaluate grant
applications.
Place: National Institute of Child Health
and Human Development, 6710B Rockledge
Drive, Room 2121D, Bethesda, MD 20892.
Contact Person: Cathy J. Wedeen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, DHHS, 6710B Rockledge
Drive, Room 2121D, Bethesda, MD 20892,
301–435–6878, wedeenc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.865, Research for Mothers
and Children, National Institutes of Health,
HHS)
Dated: April 2, 2020.
Ronald J. Livingston, Jr.,
Program Analyst,Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–07328 Filed 4–7–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Council for Complementary and
Integrative Health, Closed Session, June
05, 2020, 08:30 a.m. to 9:45 a.m. and
Open Session, June 05, 2020, 10:00 a.m.
to 04:00 p.m., National Institute of
General Medical Sciences, Natcher
Bldg., E1/E2, 45 Center Drive, Bethesda,
MD 20892 which was published in the
Federal Register on January 22, 2020, 85
FR 14, page 3707.
This notice is being amended to
change the time for the Closed Session
to June 05, 2020, 08:30 a.m. to 10:00
a.m. and the time for the Open Session
to June 05, 2020, 10:15 a.m. to 03:30
p.m., and to change the meeting location
from the NIH Natcher Bldg., Bethesda,
MD to a virtual meeting. The home page
for the National Center for
Complementary and Integrative Health
is: https://nccih.nih.gov/about/naccih,
where an agenda, NIH Videocast
service, and any additional information
for the meeting will be posted when
available. Any member of the public
may submit written comments no later
than 15 days after the meeting. The
meeting is partially closed to the public.
Dated: April 2, 2020.
Ronald J. Livingston, Jr.,
Program Analyst,Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–07326 Filed 4–7–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
19765
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK IBDGC
Ancillary Studies.
Date: May 28, 2020.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy, 6707 Democracy Boulevard,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, Division of
Extramural Activities, NIDDK, National
Institutes of Health, Room 7111, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: April 3, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–07413 Filed 4–7–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
E:\FR\FM\08APN1.SGM
08APN1
19766
Federal Register / Vol. 85, No. 68 / Wednesday, April 8, 2020 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Women’s Health Initiative Renewal.
Date: April 30, 2020.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: NIH RKL 1, 6705 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Susan Wohler Sunnarborg,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, 6705 Rockledge
Drive, Bethesda, MD 20892, 301–827–7987,
susan.sunnarborg@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: April 3, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
advocacy groups, other voluntary health
organizations, and patients and their families
to update one another on progress relevant to
the Action Plan for the Muscular Dystrophies
and to coordinate activities and discuss gaps
and opportunities leading to better
understanding of the muscular dystrophies,
advances in treatments, and improvements in
patients’ and their families’ lives. Prior to the
meeting, an agenda will be posted to the
MDCC meeting registration website: https://
meetings.ninds.nih.gov/meetings/MDCC2020.
Registration: To register, please go to:
https://meetings.ninds.nih.gov/Home/
Registration/26698.
Webcast Live: https://nih.webex.com/nih/
onstage/g.php?MTID=e1c2d0bed65aa
419911386eaa2ea2bb42.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Glen Nuckolls, Ph.D.,
Program Director, NINDS/NIH, Neuroscience
Center, 6001 Executive Blvd., Rm 2203,
Bethesda, MD 20892, 301–496–5876,
nuckollg@ninds.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
More information can be found on the
Muscular Dystrophy Coordinating Committee
home page: https://mdcc.nih.gov/.
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: May 13, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergies and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G42,
Rockville, MD 20892, (Telephone Conference
Call).
Contact Person: Sandip Bhattacharyya,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergies and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G42,
Rockville, MD 20852, sandip.bhattacharyya@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 2, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2020–07414 Filed 4–7–20; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2020–07407 Filed 4–7–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
lotter on DSKBCFDHB2PROD with NOTICES
Office of the Secretary; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Muscular Dystrophy
Coordinating Committee (MDCC).
The meeting will be open to the
public. Individuals who plan to
participate and need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the Contact Person listed
below in advance of the meeting.
Name of Committee: Muscular Dystrophy
Coordinating Committee.
Date: June 8, 2020.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: The purpose of this meeting is to
bring together committee members,
representing government agencies, patient
VerDate Sep<11>2014
18:37 Apr 07, 2020
Jkt 250001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Dated: April 2, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–07409 Filed 4–7–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Pediatrics Subcommittee.
Date: June 4, 2020.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Child Health
and Human Development, 6710B Rockledge
Drive, Rm. 2125C, Bethesda, MD 20892–7002
(Telephone Conference Call).
E:\FR\FM\08APN1.SGM
08APN1
]]>Agencies
[Federal Register Volume 85, Number 68 (Wednesday, April 8, 2020)]
[Notices]
[Pages 19765-19766]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07407]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
[[Page 19766]]
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Women's Health Initiative Renewal.
Date: April 30, 2020.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: NIH RKL 1, 6705 Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific
Review Officer, Office of Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, 6705 Rockledge Drive, Bethesda, MD 20892,
301-827-7987, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: April 3, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-07407 Filed 4-7-20; 8:45 am]
BILLING CODE 4140-01-P
